ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $407,000 | +1353.6% | 12,900 | +2604.4% | 0.00% | – |
| Q4 2019 | $28,000 | -59.4% | 477 | -74.7% | 0.00% | – |
| Q3 2019 | $69,000 | +27.8% | 1,889 | +62.3% | 0.00% | – |
| Q2 2019 | $54,000 | +5300.0% | 1,164 | +11540.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 10 | -91.9% | 0.00% | – |
| Q4 2016 | $2,000 | -99.5% | 124 | -99.6% | 0.00% | -100.0% |
| Q3 2016 | $413,000 | +18.7% | 29,855 | -15.2% | 0.00% | 0.0% |
| Q2 2016 | $348,000 | +23.0% | 35,219 | +193.5% | 0.00% | 0.0% |
| Q3 2015 | $283,000 | -42.4% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $491,000 | -11.7% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $556,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |